SEC filing
Illumina to Spin off Grail by Issuing Shares to Investors, Will Keep 14.5 Percent
Illumina shareholders will receive one share of Grail for every six shares of Illumina stock, with cash issued in lieu of fractional shares.
Nasdaq Warns OpGen About Overdue 2023 Annual Report
The molecular diagnostics firm said that it has been finalizing a Form 10-K report and plans to regain compliance with the exchange's listing requirement.
OraSure Technologies Discloses Cybersecurity Incident
The firm said that the incident has not had any impact on its core financial or operation systems and that it does not anticipate it will impact its business going forward.
The firms' merger agreement, filed with the US Securities and Exchange Commission, contradicts previous messaging on layoffs at Standard BioTools.
SEC Concludes CareDx Investigation, Recommends No Enforcement Action
The SEC informed CareDx in a letter that it had concluded an investigation into the company's accounting and public reporting practices.
Aug 10, 2023
SEC Investigating Illumina Over Grail Acquisition
Sep 2, 2021
Cue Health Files for IPO for up to $100M
Jul 19, 2021
Sophia Genetics Increases IPO Target to $221M
Jun 15, 2021
Progenity Raises $40M in Private Placement
Dec 17, 2019
Grail Raises $125M in Equity Financing Offering
Sep 30, 2019
Nasdaq Warns Biocept Over Listing Requirement
Sep 3, 2019
Fulgent Genetics to Offer $22.5M in Stock
Aug 10, 2018
Invitae Files $250M Shelf Registration
Mar 22, 2017
Alere Out of Compliance With NYSE Listing Rules
Dec 28, 2016